Your browser doesn't support javascript.
loading
Low-dose versus High-dose Carfilzomib with Dexamethasone (S1304) in Patients with Relapsed-Refractory Multiple Myeloma.
Ailawadhi, Sikander; Sexton, Rachael; Lentzsch, Suzanne; Abidi, Muneer H; Voorhees, Peter M; Cohen, Adam D; Rohren, Eric M; Heitner, Stephen; Kelly, Kevin; Mackler, Niklas J; Baer, David M; Hoering, Antje; Durie, Brian; Orlowski, Robert Z.
Afiliação
  • Ailawadhi S; Mayo Clinic, Jacksonville, Florida. ailawadhi.sikander@mayo.edu.
  • Sexton R; Cancer Research and Biostatistics, Seattle, Washington.
  • Lentzsch S; Columbia University Medical Center, New York, New York.
  • Abidi MH; Spectrum Health/Michigan State University, Grand Rapids, Michigan.
  • Voorhees PM; Levine Cancer Institute, Charlotte, North Carolina.
  • Cohen AD; Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania.
  • Rohren EM; Baylor College of Medicine, Houston, Texas.
  • Heitner S; Oregon Health & Science University, Portland, Oregon.
  • Kelly K; Norris Comprehensive Cancer Center, Los Angeles, California.
  • Mackler NJ; IHA Hem/Onc, Ann Arbor, Michigan.
  • Baer DM; Kaiser Permanente, Oakland, California.
  • Hoering A; Cancer Research and Biostatistics, Seattle, Washington.
  • Durie B; Cedars-Sinai Comprehensive Cancer Center, Los Angeles, California.
  • Orlowski RZ; The University of Texas MD Anderson Cancer Center, Houston, Texas.
Clin Cancer Res ; 26(15): 3969-3978, 2020 08 01.
Article em En | MEDLINE | ID: mdl-32299820

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Oligopeptídeos / Dexametasona / Protocolos de Quimioterapia Combinada Antineoplásica / Mieloma Múltiplo / Recidiva Local de Neoplasia Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Oligopeptídeos / Dexametasona / Protocolos de Quimioterapia Combinada Antineoplásica / Mieloma Múltiplo / Recidiva Local de Neoplasia Idioma: En Ano de publicação: 2020 Tipo de documento: Article